Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from KimberlyClark

Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger

Kleenex maker’s deal for troubled Johnson & Johnson spinoff comes amid lawsuits and regulatory scrutiny

The Guardian - US

Tylenol maker sells to Kimberly Clark for $48B weeks after Trump and RFK Jr targeted drug

The deal announced Monday is among the largest corporate takeovers of the year

The Independent UK

Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On?

Shares of Kimberly-Clark Corporation (NASDAQ:KMB) plunged 16.15% during the pre-market trading session on Monday, after it announced the acquisition of Kenvue Inc. (NYSE:KVUE) on Monday. Meanwhile Kenvue stock surged 20.04%.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Safe and Steady Stocks for Any Market

Coca-Cola, Kimberly-Clark, and Healthpeak Properties offer stable dividends and steady growth, making them safe stocks for any market environment

MarketBeat

Kimberly-Clark Proves Resilient With Firm Sales In Shifting Market

Kimberly-Clark Corporation (NASDAQ:KMB) shares were trading higher in the premarket session on Thursday after the company reported third-quarter fiscal 2025 results.

Benzinga

The Saturday Spread: Use Distributional Bifurcation to Roadmap Your Options Trades

You wouldn’t dare fly in an airplane that wasn’t equipped with a working altimeter. It’s the same principle when it comes to data science and options trading.

Barchart

Earnings Preview: What to Expect From Kimberly-Clark’s Report

Consumer staples giant Kimberly-Clark will report its Q3 results soon. What should you expect from it?

Barchart

Read news from The Economist, FT, and more,
with one subscription

Investing Freebies: Perks You Get for Owning These Stocks

The biggest returns for investors come over the long term, but these companies offer instant gratification for shareholders with several freebies and perks.

Kiplinger

Is Kimberly-Clark Stock Underperforming the S&P 500?

Kimberly-Clark has lagged behind the broader S&P 500 Index over the past year, yet analysts on Wall Street remain moderately optimistic about its future prospects.

Barchart

Kimberly-Clark To Pay Around $40 Million Over Surgical Gown Designs

Kimberly-Clark Corporation (NASDAQ:KMB) will pay $40.4 million to settle a criminal charge related to selling adulterated MicroCool surgical gowns.

Benzinga

Kimberly-Clark Analysts Boost Their Forecasts After Upbeat Q2 Earnings

Kimberly-Clark Corporation (NASDAQ:KMB) posted better-than-expected earnings for the second quarter on Friday.

Benzinga

Kimberly-Clark's Quarterly Earnings Preview: What You Need to Know

Kimberly-Clark is set to report its second-quarter results later this month, and analysts are forecasting a double-digit drop in earnings.

Barchart

Triple Your Kimberly-Clark Dividend with this Options Strategy

With markets becoming more volatile, investors might be more interested in generating income rather than capital gains. Using options we can more than triple the yield on our KMB shares by using a covered call strategy.

Barchart

How Is Kimberly-Clark's Stock Performance Compared to Other Consumer Defensive Stocks?

Although Kimberly-Clark has performed better than its industry peers over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Do Wall Street Analysts Like Kimberly-Clark Stock?

As Kimberly-Clark has lagged behind the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Space

Astronaut Scott Kelly joins 'Mission Dry', stars in Goodnites underwear campaign film

Astronauts are helping to destigmatize a childhood experience by pointing out the similarities between what some kids wear to bed and what explorers wear into space.

MarketBeat

Dividend King Kimberly-Clark Is a Good Buy in 2025

High-yielding Dividend King Kimberly-Clark is well-positioned to sustain its capital return in 2025. The stock price is setting up to continue the uptrend.

The Independent UK

Tackling tariffs: What some companies are saying, and doing, about tariffs

Tariffs have been forcing companies to give somewhat shaky financial forecasts during their latest round earnings updates

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

4 Stocks With +3% Yields and 50+ Years of Dividend Increases

See these four stocks with hefty dividend yields and some of the longest track records of increasing dividends throughout the years.

Barchart

Kimberly-Clark Stock: Is KMB Outperforming the Consumer Defensive Sector?

Although Kimberly-Clark has outperformed relative to the consumer defensive sector over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

Kimberly-Clark Stock Outlook: Is Wall Street Bullish or Bearish?

Kimberly-Clark has trailed the broader market over the past year, and Wall Street analysts remain cautious about its future outlook.

MarketBeat

Kimberly-Clark: A Regal Opportunity in This Dividend King

Kimberly-Clark's high-yielding dividend is safe for 2025 and likely to grow at the end of the fiscal year. A turn-around is in process and gaining traction.

Barchart

Kimberly-Clark Earnings Preview: What to Expect

Kimberly-Clark is set to announce its fourth-quarter earnings later this month, with analysts projecting a slight decline in earnings.

Barchart

Is Kimberly-Clark Stock Underperforming the Dow?

Kimberly-Clark has underperformed the Dow Jones Industrial in recent trading, yet analysts maintain a moderately optimistic outlook for the stock's future.

Barchart

Are Wall Street Analysts Predicting Kimberly-Clark Stock Will Climb or Sink?

Kimberly-Clark has underperformed the broader market over the past year, yet analysts maintain a reasonably bullish stance on its future prospects.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.